Results 71 to 80 of about 3,282 (184)

Profile of netupitant/palonosetron (NEPA) fixed dose combination and its potential in the treatment of chemotherapy-induced nausea and vomiting (CINV)

Drug Design, Development and Therapy, 2014
Rudolph M Navari Cancer Care Program, Eastern Europe, World Health Organization, Mishawaka, IN, USA; Indiana University School of Medicine, South Bend, IN, USA; South Bend Medical Services Corporation, IN, USA Abstract: Chemotherapy-induced ...
Navari RM
doaj  

Informe técnico palonosetron inyectable

, 2013
Revisada la evidencia observamos una ventaja de hasta 19% en disminución en emesis aguda en regímenes altamente emetogénicos. Respecto a la seguridad es similar a la terapia estándar aunque reportes muestran una cierta ventaja respecto a la prolongación del intervalo QT, sin embargo las múltiples interacciones medicamentosas por el CYP3A4 y CYP2C9 ...
openaire   +2 more sources

Efficacy and Safety of Intravenous Palonosetron against Ondansetron in Preventing Postoperative Nausea Vomiting in Patients Undergoing General Anaesthesia: Double blind Randomized Control Study in Tertiary Care Hospital, Tamil Nadu, India

, 2022
Sunil Mhatarba Vishwasrao, Sufala Sunil Vishwasrao, Amar Nagesh Kumar   +2 more
openalex   +1 more source

Palonosetron in the prevention of chemotherapy-induced nausea and vomiting: an evidence-based review of safety, efficacy, and place in therapy

, 2015
Luigi Celio, Monica Niger, Francesca Ricchini, Francesco Agustoni   +3 more
openalex   +2 more sources

Intravenous palonosetron and pethidine as prophylaxis of post spinal shivering: A comparative study

, 2022
Chandan Kumar Banik, Prosanjit Mazumder, Gopa Kundu, Shamim Ara Begum   +3 more
openalex   +2 more sources

Application of Box-Behnken design for optimization of A RP-HPLC method for determination of palonosetron and netupitant in their combined dosage form in presence of their impurities

, 2022
Mohamed A. ElHamid, Ehab F. Elkady, Eman A. Mostafa   +2 more
openalex   +2 more sources

Palonosetron, a 5-HT3 Receptor Antagonist, Induces G1 Cell Cycle Arrest and Autophagy in Gastric Cancer Cells. [PDF]

Int J Mol Sci
Yoo YC, Lin L, Lee S, Shin YR, Oh JE, Kim NY.   +5 more
europepmc   +1 more source

Cardiotoxicity of different 5-HT3 receptor antagonists analyzed using the FAERS database and pharmacokinetic study. [PDF]

Sci Rep
Cai Y, Luo S, Lin S, Huang X, Wang X, Yang L, Xu X, Weng X.   +7 more
europepmc   +1 more source

“A comparison of ondansetron and palonosetron for prevention of post-operative nausea and vomiting in patients undergoing elective abdominal surgeries under general anaesthesia” A randomized double blind study

, 2015
Alpana Arya, Shilpi Jain, Suresh Chandra Dulara, Loveleena Gupta   +3 more
openalex   +1 more source

A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC) [PDF]

, 2017
L. Zhang, Shun Lü, J. Feng, Arunee Dechaphunkul, J. Chang, D. Wang, Salvatore Chessari, Corinna Lanzarotti, Karin Jordan, Matti Aapro   +9 more
openalex   +1 more source